Dynatrace had its Relative Strength (RS) Rating upgraded from 78 to 81 Friday.
IBD's proprietary rating tracks market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the last 52 weeks holds up against all the other stocks in our database.
History shows that the best stocks tend to have an RS Rating north of 80 as they launch their biggest climbs.
Looking For The Best Stocks To Buy And Watch? Start Here
The IBD Big Cap 20 stock is still inside a buying range after breaking past a 59.80 entry in a cup with handle. The proper buying range is up to 5% above the initial entry. Once a stock hits that benchmark, it's best to wait for it to set up another buying opportunity.
Dynatrace posted 16% earnings growth last quarter. Revenue gains came in at 19%.
The company holds the No. 9 rank among its peers in the Computer Software-Enterprise industry group. Enfusion, Samsara and Klaviyo are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
